DENVER--(BUSINESS WIRE)--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback